Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00252512 · ClinicalTrials.gov registry record · NA
The Effect of a Contingency Management Intervention on Substance Use
A NA study of Substance Use Disorders, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
- 2
- Study locations
NCT00252512: Completed NA study of Substance Use Disorders, sponsored by VA Office of Research and Development.
NCT00252512 is a NA study of Substance Use Disorders that has completed, run by VA Office of Research and Development. The registered enrollment target is 332 participants, below the 497-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (33% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00252512, a NA study of Substance Use Disorders, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
- 2
- Study locations
Study Summary
Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending outpatient substance use disorders treatment.
Conditions Studied
Interventions
- OTHER Placebo
- BEHAVIORAL Contingency Management
Study Locations (2)
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-02 |
| Phase | NA |
What the finished NCT00252512 record still lists
NCT00252512 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 497-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (33% lower).
The record links to 1 condition, with Substance Use Disorders appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00252512 reports a single indexed study location in Minnesota, Washington.
Frequently Asked Questions
What is clinical trial NCT00252512 about?
NCT00252512 is a clinical study titled "The Effect of a Contingency Management Intervention on Substance Use". Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending out...
What is the current status of trial NCT00252512?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2007-05. Estimated completion is 2010-02.
What conditions does trial NCT00252512 study?
This clinical trial studies the following conditions: Substance Use Disorders.
What interventions are being tested in trial NCT00252512?
The interventions under investigation include: Placebo (OTHER), Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00252512?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00252512 being conducted?
This trial has 2 study locations across Minnesota, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00252512's enrollment target sits among peer trials
332 17th of 93 higher than 77 of 93 other Substance Use Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
-
Trauma Screening/Referral and Interpersonal Violence Prevention for Women with Substance Use Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia